Skip to content

Predictive model for lymph node metastasis of colorectal cancer - using PET / CT

Predictive model for lymph node metastasis of colorectal cancer - using PET / CT - Predictive model for lymph node metastasis of colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029549
Enrollment
200
Registered
2017-11-01
Start date
2017-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Sponsors

Southern Tohoku General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as colorectal cancer pathologically (adenocarcinoma, pap / tub / por) and planned to undergo curative surgery 2. Patients diagnosed as advanced cancer by colonoscopy or barium enema 3. Patients planned to undergo enhanced CT and PET / CT

Exclusion criteria

Exclusion criteria: 1. Patients who underwent neoadjuvant therapy (chemotherapy or radiotherapy) 2. Patients who underwent colon surgery, except appendectomy 3. Patients who have poor-controlled diabetes mellitus (Blood sugar was over 200 mg/dL when PET / CT was performed) 4. Patients who have renal dysfunction 5. Patients who have allergy to contrast agent

Design outcomes

Primary

MeasureTime frame
Accuracy of the predictive model for lymph node metastasis of colorectal cancer

Countries

Japan

Contacts

Public ContactYukitoshi Todate

Southern Tohoku General Hospital Department of Surgery

totty.todate@gmail.com024-934-5322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026